SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General statement of acquisition of beneficial ownership:
SEC Accession No. 0001193125-20-190857
Filing Date
2020-07-10
Accepted
2020-07-10 09:26:59
Documents
2
Group Members
PIVOTAL BIOVENTURE PARTNER FUND I G.P., L.P.PIVOTAL BIOVENTURE PARTNERS FUND I U.G.P., LTD.

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13D d88788dsc13d.htm SC 13D 78922
2 EXHIBIT 1 d88788dex991.htm EX-99.1 6972
  Complete submission text file 0001193125-20-190857.txt   87604
Mailing Address 501 SECOND STREET, SUITE 200 SAN FRANCISCO CA 94107
Business Address 501 SECOND STREET, SUITE 200 SAN FRANCISCO CA 94107 (345) 949 1040
Pivotal bioVenture Partners Fund I, L.P. (Filed by) CIK: 0001695076 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 0331
Type: SC 13D

Mailing Address 645 SUMMER STREET, SUITE 200 BOSTON MA 02210
Business Address 645 SUMMER STREET, SUITE 200 BOSTON MA 02210 857-245-5715
Akouos, Inc. (Subject) CIK: 0001722271 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-91555 | Film No.: 201021984
SIC: 2834 Pharmaceutical Preparations